Literature DB >> 21474651

Toll-like receptor 3 signaling enables human esophageal epithelial cells to sense endogenous danger signals released by necrotic cells.

Diana M Lim1, Mei-Lun Wang.   

Abstract

The mechanisms by which gastroesophageal reflux disease esophagitis develops are controversial. Although many support the notion that caustic injury leads to reflux esophagitis, others have proposed that reflux esophagitis is caused by esophageal epithelial cytokine-mediated inflammation. We previously demonstrated that Toll-like receptor 3 (TLR3) is highly expressed and functional in the nontransformed human esophageal epithelial cell line EPC2-hTERT. In addition to activation by viral double-stranded RNA, TLR3 can be activated by endogenous mRNA released by necrotic cells. In the present study, we investigated the role of esophageal epithelial TLR3 to sense danger signals released by necrotic esophageal epithelial cells in vitro. Following induction of freeze-thaw necrosis, necrotic EPC2-hTERT cell supernatants (NCS) were used to stimulate EPC2-hTERT monolayers, leading to NF-κB-dependent induction of IL-8 mRNA expression. Responses to self-derived NCS were not observed in transformed gastrointestinal epithelial cell lines, including TE-1 and Caco-2 cells, suggesting that the ability to sense endogenous danger signals is unique to nontransformed esophageal epithelial cells. To determine the immunostimulatory role of epithelial RNA, EPC2-hTERT cells were stimulated with self-derived mRNA, which significantly induced IL-8 mRNA expression. Finally, suppression of TLR3 signaling in a DN-TLR3 cell line, hTERT-ΔTIR-TLR3, led to reduced NCS-induced IL-8 induction by both NCS and mRNA stimulation. Our results demonstrate that human esophageal epithelial cells can sense endogenous danger signals, in part through TLR3 signaling. This supports the concept that epithelial injury plays an inciting role in the pathogenesis of reflux-induced esophagitis, providing important insights into the mechanisms by which epithelial injury leads to inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474651      PMCID: PMC3129934          DOI: 10.1152/ajpgi.00471.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  56 in total

Review 1.  Mechanisms of reflux-induced epithelial injuries in the esophagus.

Authors:  R C Orlando
Journal:  Am J Med       Date:  2000-03-06       Impact factor: 4.965

2.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  HCl-induced cell edema in rabbit esophageal epithelium: a bumetanide-sensitive process.

Authors:  N A Tobey; E J Cragoe; R C Orlando
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

4.  Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo.

Authors:  Claudia D Andl; Takaaki Mizushima; Hiroshi Nakagawa; Kenji Oyama; Hideki Harada; Katerina Chruma; Meenhard Herlyn; Anil K Rustgi
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

5.  Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease.

Authors:  Hajime Isomoto; Vladimir A Saenko; Yusei Kanazawa; Yoshito Nishi; Akira Ohtsuru; Kenichiro Inoue; Yuko Akazawa; Fuminao Takeshima; Katsuhisa Omagari; Masanobu Miyazaki; Yohei Mizuta; Ikuo Murata; Shunichi Yamashita; Shigeru Kohno
Journal:  Am J Gastroenterol       Date:  2004-04       Impact factor: 10.864

6.  The inhibitor of I kappa B alpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices.

Authors:  F Goffi; F Boroni; M Benarese; I Sarnico; A Benetti; P F Spano; M Pizzi
Journal:  Neurosci Lett       Date:  2004-12-28       Impact factor: 3.046

7.  Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A.

Authors:  Ni Cheng; Rong He; Jun Tian; Patrick P Ye; Richard D Ye
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

9.  Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling.

Authors:  Behnam Naderi Kalali; Gabriele Köllisch; Jörg Mages; Thomas Müller; Stefan Bauer; Hermann Wagner; Johannes Ring; Roland Lang; Martin Mempel; Markus Ollert
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

10.  The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury.

Authors:  Jaklien C Leemans; Loes M Butter; Wilco P C Pulskens; Gwendoline J D Teske; Nike Claessen; Tom van der Poll; Sandrine Florquin
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more
  17 in total

1.  Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro.

Authors:  Amanda B Muir; Diana M Lim; Alain J Benitez; Prasanna Modayur Chandramouleeswaran; Anna J Lee; Eduardo D Ruchelli; Jonathan M Spergel; Mei-Lun Wang
Journal:  Exp Cell Res       Date:  2012-12-10       Impact factor: 3.905

2.  Human esophageal myofibroblasts secrete proinflammatory cytokines in response to acid and Toll-like receptor 4 ligands.

Authors:  Matthew Gargus; Chao Niu; John G Vallone; Jana Binkley; Deborah C Rubin; Anisa Shaker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-01       Impact factor: 4.052

3.  Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea.

Authors:  Yung-Che Chen; Mao-Chang Su; Chia-Wei Liou; Shih-Feng Liu; Chung-Jen Chen; Hsin-Ching Lin; Chang-Chun Hsiao; Ting-Ya Wang; Chin-Chou Wang; Chien-Hung Chin; Kuo-Tung Huang; An-Shen Lin; Meng-Chih Lin
Journal:  Sleep Breath       Date:  2015-01-22       Impact factor: 2.816

4.  Toll-like receptor 2 stimulation augments esophageal barrier integrity.

Authors:  Melanie A Ruffner; Li Song; Kelly Maurer; Lihua Shi; Margaret C Carroll; Joshua X Wang; Amanda B Muir; Jonathan M Spergel; Kathleen E Sullivan
Journal:  Allergy       Date:  2019-07-25       Impact factor: 13.146

5.  Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinoma.

Authors:  Olli Helminen; Heikki Huhta; Petri P Lehenkari; Juha Saarnio; Tuomo J Karttunen; Joonas H Kauppila
Journal:  Oncoimmunology       Date:  2016-01-25       Impact factor: 8.110

6.  Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors.

Authors:  Angelica Brandelius; Irma Mahmutovic Persson; Jenny Calvén; Leif Bjermer; Carl G A Persson; Morgan Andersson; Lena Uller
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

7.  Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via Toll-like receptor 7 signaling.

Authors:  Yan Feng; Hongliang Chen; Jiayan Cai; Lin Zou; Dan Yan; Ganqiong Xu; Dan Li; Wei Chao
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

8.  Rhinovirus and dsRNA induce RIG-I-like receptors and expression of interferon β and λ1 in human bronchial smooth muscle cells.

Authors:  Jenny Calvén; Yuliana Yudina; Lena Uller
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

9.  Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.

Authors:  Meliha Mehmeti; Roni Allaoui; Caroline Bergenfelz; Lao H Saal; Stephen P Ethier; Martin E Johansson; Karin Jirström; Karin Leandersson
Journal:  Breast Cancer Res       Date:  2015-09-22       Impact factor: 6.466

Review 10.  The role of pattern recognition receptors in intestinal inflammation.

Authors:  M Fukata; M Arditi
Journal:  Mucosal Immunol       Date:  2013-03-20       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.